The Motley Fool

TSX:GUD (KNIGHT THERAPEUTICS INC)

$6.98 $-0.01 (0.00) Tuesday, July 14, 2020 at 4:00:00 p.m. Eastern Daylight Time

About

Last updated Jul 14, 2020, 04:00:00pm EDT
Current Price $6.98
Today's Change $-0.01 (-0.1%)
Close Price $6.98
Open Price $6.98
Bid $6.94
Ask $7.00
Day Range $6.82 - $7.02
Year Range $4.73 - $8.88
Volume 217,898
Average Volume 252,220
Market Cap $915,259,541.00
EPS (ttm) $0.06

Related Articles

Top TSX Stocks Under $10

Ambrose O'Callaghan | June 26, 2020

Markets have been somewhat volatile to close out this month, so investors should target TSX stocks that are on the cheaper side right now. More »

2 TSX Pharma Stocks That Can Make You a TFSA Millionaire

Aditya Raghunath | June 21, 2020

Here's why you can buy shares of Viemed Healthcare and Knight Therapeutics right now! More »

TFSA: 3 Healthcare Stocks That Can Make You Filthy Rich

Ambrose O'Callaghan | June 3, 2020

TFSA investors should be on the hunt for the kind of growth offered by healthcare stocks like Knight Therapeutics Inc. (TSX:GUD) in 2020 and... More »

TFSA Investors: 2 Healthcare Stocks to Buy in May

Ambrose O'Callaghan | May 9, 2020

It has been a wild 2020, but TFSA investors should target exciting healthcare stocks like Knight Therapeutics Inc. (TSX:GUD) to start the month of... More »

TFSA Investors: 2 Growth Stocks I’m Buying If the Market Selloff Gets Worse

Ambrose O'Callaghan | March 8, 2020

During turbulent economic times, investors usually want to dial back risk and retreat to stable income vehicles. However, recent history has shown us how... More »

Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!

Nikhil Kumar | May 24, 2019

Does the genius of CEO Jonathan Goodman of Knight Therapeutics Inc. (TSX:GUD) come for free? More »

Growth Investors: This Stock Could Easily Turn $10,000 Into $100,000

Nelson Smith | April 2, 2019

Jonathan Goodman and Knight Therapeutics Inc. (TSX:GUD) could be the market's next great growth story. Are you willing to let this opportunity pass? More »

Revealed: 5 Top Growth Picks From This Award-Winning Mutual Fund

Nelson Smith | November 5, 2018

One of Canada's best mutual funds is investing in small-cap growth companies like Freshii Inc. (TSX:FRII), Aritzia Inc. (TSX:ATZ), and Sierra Wireless, Inc. (TSX:SW)(NASDAQ:SWIR).... More »

5 Reasons Why This Pharma Stock Is Poised for Takeoff

Kenrick Vassall | August 4, 2018

Knight Therapeutics Inc. (TSX:GUD) has an effective low-risk strategy combined with one of the best balance sheets in the industry. More »

Can Knight Therapeutics Inc. Repeat the Success of Paladin Labs?

Karen Thomas, MSc, CFA | May 18, 2017

Knight Therapeutics Inc. (TSX:GUD) offers investors exposure to the lucrative specialty pharmaceutical market. More »